We are live on ! Find out more
ADAG

Adagene

15 hedge funds and large institutions have $29.7M invested in Adagene in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 15.39%15.43% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less funds holding

Funds holding: 1615 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

56% less capital invested

Capital invested by funds: $67.3M → $29.7M (-$37.6M)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
3
Reduced
6
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ADAG Hedge Fund Activity: Q1 2022 in Review

15 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q1 2022, worth a combined $29.7M — down 56% from $67.3M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ADAG and 1 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 3 added.

The largest buyer was Strategic Vision Investment, adding an estimated $3.91M. The largest seller was OrbiMed, exiting entirely with an estimated $2.12M sold.

  • 15 institutional investors held Adagene (ADAG) as of Q1 2022, down from 16 in Q4 2021.
  • Funds reported $29.7M of Adagene stock for Q1 2022, down 56% quarter-over-quarter.
  • 1 fund opened new Adagene positions in Q1 2022 and 2 closed out, a net change of -1 holder.
  • The largest Adagene buyer in Q1 2022 was Strategic Vision Investment, an estimated $3.91M added.
  • The largest Adagene seller in Q1 2022 was OrbiMed, an estimated $2.12M sold.

Based on aggregated 13F filings for Q1 2022.